# XG005 for Pain Control in Subjects Undergoing Bunionectomy

> **NCT06017999** · PHASE2,PHASE3 · COMPLETED · sponsor: **Xgene Pharmaceutical Group** · enrollment: 450 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** XG005 tablet
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT06017999
- **Lead sponsor:** Xgene Pharmaceutical Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-29
- **Primary completion:** 2024-08-29
- **Final completion:** 2024-09-30
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06017999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06017999, "XG005 for Pain Control in Subjects Undergoing Bunionectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06017999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*